wb 4101 has been researched along with Prostatic Neoplasms in 1 studies
N-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine : A benzodioxine that is 2,3-dihydro-1,4-benzodioxine bearing a [(2',6'-dimethoxyphenoxy)ethylamino]methyl group at position 2. An alpha1A-adrenergic selective antagonist.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Here, by using two human prostate cancer epithelial (hPCE) cell models - primary cells from resection specimens (primary hPCE cells) and an LNCaP (lymph node carcinoma of the prostate) cell line - we identify an alpha1A subtype of adrenergic receptor (alpha1A-AR) and show its functional coupling to plasmalemmal cationic channels via direct diacylglycerol (DAG) gating." | 1.32 | Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells. ( Bonnal, JL; Dewailly, E; Lemonnier, L; Mauroy, B; Prevarskaya, N; Roudbaraki, M; Shuba, Y; Skryma, R; Slomianny, C; Sydorenko, V; Thebault, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thebault, S | 1 |
| Roudbaraki, M | 1 |
| Sydorenko, V | 1 |
| Shuba, Y | 1 |
| Lemonnier, L | 1 |
| Slomianny, C | 1 |
| Dewailly, E | 1 |
| Bonnal, JL | 1 |
| Mauroy, B | 1 |
| Skryma, R | 1 |
| Prevarskaya, N | 1 |
1 other study available for wb 4101 and Prostatic Neoplasms
| Article | Year |
|---|---|
Alpha1-adrenergic receptors activate Ca(2+)-permeable cationic channels in prostate cancer epithelial cells.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Blotting, Western; Boron Comp | 2003 |